NICOTINE POLACRILEX
| Brand name | NICORETTE |
|---|---|
| Active ingredient | NICOTINE POLACRILEX |
| Strength | EQ 2MG BASE |
| Dosage form | TROCHE/LOZENGE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2009 |
| Marketing status | OTC |
| Patent | Expires | Type |
|---|---|---|
| 8501164 | June 2029 | product |
| 8940772 | April 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.